Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma.
de Mel S, Rashid MBM, Zhang XY, Goh J, Lee CT, Poon LM, Chan EHL, Liu X, Chng WJ, Chee YL, Lee J, Yuen YC, Lim JQ, Chia BKH, Laurensia Y, Huang D, Pang WL, Cheah DMZ, Wong EKY, Ong CK, Tang T, Lim ST, Ng SB, Tan SY, Loi HY, Tan LK, Chow EK, Jeyasekharan AD.
de Mel S, et al. Among authors: lee j, lee ct.
Blood Cancer J. 2020 Jan 27;10(1):9. doi: 10.1038/s41408-020-0276-7.
Blood Cancer J. 2020.
PMID: 31988286
Free PMC article.
No abstract available.